Failure intelligence, not failure trivia
F Failurepedia

Direct-to-Consumer Mattresses and Bedding

Casper Sleep

Casper pioneered the direct-to-consumer "bed in a box" mattress and was valued at $1.1 billion in a 2019 private funding round. By the time it went public in February 2020, competition from dozens of copycat DTC brands and incumbent mattress makers had driven up marketing costs and squeezed margins, and the IPO valued the company at under $600 million. The stock fell further as losses continued, and in 2022 private equity firm Durational Capital Management took Casper private again at a fraction of its earlier value.

Failed strategy Acquired Moderate
Company
Casper Sleep
Started
2014
Ended
2022
Private-market valuation at the April 2019 Series D round
$1.1B
Collapse speed
Gradual
Preventability
Medium
Lesson transfer
Industry-wide
Last reviewed
2026-08-06

Narrative

The story

The ambition

Casper launched in 2014 with a simple pitch: one mattress, compressed and shipped in a box, sold directly to consumers online and delivered to the door within days, skipping the showroom markup and commissioned salesperson that had defined mattress buying for decades. The company built a strong consumer brand around sleep as a category, expanded into pillows, sheets, and other bedding, and became the public face of the direct-to-consumer "unbundling" wave working its way through retail. Investors treated it as a category-defining startup, not just a mattress seller.

The rise

Casper's growth drew serious capital. By April 2019 the company had raised a $100 million Series D round from existing backers including Target, NEA, IVP, and Norwest Venture Partners, pushing its private valuation to $1.1 billion and cementing its place among venture-backed "unicorns". Total funding to that point exceeded $300 million. Casper had opened physical retail stores, expanded internationally, and built revenue past $400 million, and an initial public offering looked like the natural next step for the brand that had created the DTC mattress category.

The cracks

The category Casper had created quickly filled with imitators. Purple, Tuft & Needle, Leesa, and Nectar all sold a similar bed-in-a-box product online, and established manufacturers began adapting to compete directly with the upstarts. With little to differentiate one foam mattress-in-a-box from another beyond marketing, customer acquisition costs rose across the category, and Casper's dependence on paid advertising to keep growing became more expensive every year. Analysts flagged the same structural problem repeatedly in the run-up to its IPO: mattresses are bought rarely, so a DTC brand cannot rely on repeat purchases to offset the cost of winning a customer, and Casper had not shown a credible path to profitability even as revenue grew.

The collapse

Casper filed to go public in early 2020 aiming for a valuation as high as roughly $768 million at the top of its initial range, itself a steep step down from the $1.1 billion private valuation of less than a year earlier. Investor demand fell short even of that lower bar. The company priced its IPO on February 5, 2020 at $12 a share, the bottom of an already reduced range, selling 8,350,000 shares to raise about $100.2 million and valuing the company at roughly $575 million, near half its 2019 private valuation. Casper began trading on the NYSE the next day under the ticker CSPR. The company then lost money every quarter it was public. Through the first nine months of 2021 alone it posted a net loss of about $80 million, and its stock fell more than 70% in the months before its take-private deal was announced, even as pandemic demand for home goods briefly boosted the broader mattress market. On November 15, 2021, Casper's board agreed to sell the company to private equity firm Durational Capital Management for $6.90 a share, a total deal value of roughly $300 million, a 94% premium to where the beaten-down stock was trading but still far below the IPO price and a fraction of the 2019 private valuation. The deal closed in early 2022, ending Casper's run as a public company after two years.

The aftermath

Casper's take-private sale erased most of the value venture investors had assigned it in 2019 and left public shareholders who bought at the IPO with a deep loss; the $6.90 deal price was little more than half the $12 IPO price and a small fraction of the roughly $19 implied by the top of Casper's original IPO range. Under Durational's ownership, Casper operated outside public markets and public scrutiny of its finances. The company was later sold again, to foam manufacturer Carpenter Co. in 2024, a transaction outside the scope of this case. The DTC mattress category Casper had pioneered consolidated significantly in the years after its IPO, as high customer acquisition costs proved to be a structural problem for most of the brands built the same way, not a Casper-specific failure.

The lessons

Casper is a case of a real product innovation, a compressed mattress sold directly online, that could not convert a first-mover advantage into a durable business once the innovation itself was easy to copy. The company won the category it created and then discovered the category had almost no moat: any competitor with capital could ship a similar mattress in a similar box, which left brand marketing as the main lever for growth and turned customer acquisition into an arms race that ate the margin a low-repeat-purchase product like a mattress needs to be profitable. Going public did not fix that economics problem, it just exposed it to public markets that priced the company well below what private investors had assumed a year earlier, and continued losses as a public company left it vulnerable to a going-private sale on unfavorable terms. The lesson generalizes past mattresses: a DTC brand built on paid acquisition needs either a defensible product edge or a purchase pattern that rewards repeat business, and Casper had neither once the category commoditized.

Causal timeline

Failure Anatomy

  1. 2014

    Casper launches the bed-in-a-box category

    Founded in 2014, Casper built a consumer brand around a mattress compressed and shipped directly to buyers, skipping traditional mattress retail. [1]

  2. 2019-04

    Series D values Casper at $1.1 billion

    In April 2019 Casper raised $100 million from Target, NEA, IVP, and Norwest Venture Partners at a $1.1 billion private valuation, even as its category filled with well-funded competitors like Purple, Tuft & Needle, and Leesa. [2] [3]

    Stronger competitor
  3. 2020-02-05

    IPO prices well below the private valuation

    Casper priced its IPO on February 5, 2020 at $12 a share, the bottom of a reduced range, raising about $100.2 million and valuing the company at roughly $575 million, near half its 2019 private valuation. [4]

    Unsustainable economics
  4. 2021-09

    Losses continue as a public company

    Casper lost money every quarter after going public, including a net loss of about $80 million through the first nine months of 2021, as customer acquisition costs stayed high across the crowded DTC mattress category. [5] [6]

    Unsustainable economics
  5. 2021-11-15

    Stock falls more than 70%, and Durational takes Casper private

    After the stock fell more than 70% in the months before November 2021, Casper's board agreed to sell to Durational Capital Management for $6.90 a share, a roughly $300 million deal, a 94% premium to the depressed stock price but far below the IPO and 2019 private valuations. [7]

    Unsustainable economics

Structured analysis

What Went Wrong

Root causes

Marketing spend outpaced the economics of a rarely repurchased product. Mattresses are bought infrequently, so Casper could not offset rising customer acquisition costs with repeat purchases, and its dependence on paid marketing to grow made sustained profitability elusive even as revenue increased. [6]

The DTC mattress category Casper created filled with copycats. Purple, Tuft & Needle, Leesa, and Nectar all launched similar bed-in-a-box products, and established manufacturers adapted to compete directly, commoditizing the category Casper had pioneered and driving up the cost of customer acquisition across the board. [3] [6]

Contributing factors

Continued losses as a public company. Casper lost money every quarter after its IPO, including a net loss of about $80 million through the first nine months of 2021, undermining investor confidence in its path to profitability. [5]

Growth-at-all-costs private-market valuation collided with public scrutiny. Casper's $1.1 billion 2019 private valuation reflected unicorn-era enthusiasm for growth over profitability; when it reached public markets, investors applied a much harsher standard and priced the IPO near half that figure. [2] [4]

Immediate trigger

Sustained stock decline made Casper a take-private target. Casper's stock fell more than 70% in the months before November 2021, and with the company still unprofitable, its board accepted a going-private offer from Durational Capital Management at $6.90 a share. [7]

Visible symptoms

IPO priced at roughly half the 2019 private valuation. Casper's IPO valued the company at about $575 million, near half the $1.1 billion private valuation it had carried less than a year before, an early public signal that investors doubted its growth-stage assumptions. [4]

Losses continued every quarter as a public company. Casper never posted a profitable quarter after going public, including an approximately $80 million net loss through the first nine months of 2021. [5]

Warning signs

Analysts flagged the profitability problem before the IPO even priced. Coverage of Casper's IPO filing highlighted that its biggest hurdle was proving a viable path to profitability in a highly competitive, commoditized category, months before the stock began trading. [3]

Affected groups

InvestorsEmployees

Keep reading

  • Blue Apron

    A parallel direct-to-consumer IPO whose stock also collapsed as category commoditization ate its margins.

Evidence

Claims & sources

Every numbered marker in the analysis links to the claim it rests on, and each claim to its sources.

  1. [1]

    Casper launched in 2014 selling a compressed, bed-in-a-box mattress directly to consumers online.

    Moderate Fact Mattress startup Casper said to be valued at $1.1B with new funding
  2. [2]

    In April 2019 Casper raised a $100 million Series D round from Target, NEA, IVP, and Norwest Venture Partners at a $1.1 billion private valuation, with total funding to date of about $340 million.

    Moderate Fact Mattress startup Casper said to be valued at $1.1B with new funding
  3. [3]

    Casper's direct competitors in the direct-to-consumer mattress category included Purple, Tuft & Needle, Leesa, and Nectar, and analysts flagged achieving profitability in that crowded category as Casper's central challenge ahead of its IPO.

    Moderate Reported explanation Mattress startup Casper said to be valued at $1.1B with new funding Online mattress retailer Casper slashes IPO valuation
  4. [4]

    Casper's IPO priced on February 5, 2020 at $12 a share, the bottom of a reduced range, raising about $100.2 million and valuing the company at roughly $575 million, well below the top of its initial range (about $768 million) and near half its April 2019 private valuation of $1.1 billion.

    Moderate Fact Casper Announces Pricing of Initial Public Offering Online mattress retailer Casper slashes IPO valuation
  5. [5]

    Casper lost money every quarter it was a public company, including a net loss of about $80 million through the first nine months of 2021.

    Moderate Fact Casper Will Recuperate With Private Equity After A 70% Plunge In Its Stock Price
  6. [6]

    Rising customer acquisition costs across a crowded direct-to-consumer mattress category, combined with the infrequent repurchase cycle of mattresses, made sustained profitability difficult for Casper even as established brands adopted its direct-to-consumer model.

    Moderate Reported explanation Casper Will Recuperate With Private Equity After A 70% Plunge In Its Stock Price Online mattress retailer Casper slashes IPO valuation
  7. [7]

    Casper's stock fell more than 70% in the months before November 2021, and on November 15-16, 2021 its board agreed to a take-private sale to Durational Capital Management at $6.90 a share, a roughly $300 million deal representing a 94% premium to the pre-announcement stock price.

    Moderate Fact Casper Will Recuperate With Private Equity After A 70% Plunge In Its Stock Price Durational to acquire Casper Sleep in take-private deal

Sources